V M Gordon

3.0k total citations · 1 hit paper
23 papers, 2.5k citations indexed

About

V M Gordon is a scholar working on Molecular Biology, Genetics and Biotechnology. According to data from OpenAlex, V M Gordon has authored 23 papers receiving a total of 2.5k indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 7 papers in Genetics and 7 papers in Biotechnology. Recurrent topics in V M Gordon's work include Bacterial Genetics and Biotechnology (7 papers), Bacillus and Francisella bacterial research (6 papers) and Toxin Mechanisms and Immunotoxins (6 papers). V M Gordon is often cited by papers focused on Bacterial Genetics and Biotechnology (7 papers), Bacillus and Francisella bacterial research (6 papers) and Toxin Mechanisms and Immunotoxins (6 papers). V M Gordon collaborates with scholars based in United States, Austria and Canada. V M Gordon's co-authors include Stephen H. Leppla, Erik L. Hewlett, Kurt R. Klimpel, K Paull, Marianne Oskarsson, Nicholas S. Duesbery, Natalie G. Ahn, Kenji Fukasawa, Terry D. Copeland and Craig P. Webb and has published in prestigious journals such as Science, Journal of Biological Chemistry and FEBS Letters.

In The Last Decade

V M Gordon

23 papers receiving 2.4k citations

Hit Papers

Proteolytic Inactivation of MAP-Kinase-Kinase by Anthrax ... 1998 2026 2007 2016 1998 250 500 750

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
V M Gordon United States 16 1.5k 804 637 589 455 23 2.5k
Markus Stein Canada 27 1.3k 0.8× 890 1.1× 1.2k 1.8× 1.8k 3.0× 1.1k 2.3× 45 4.4k
M.C. Prévost France 13 1.1k 0.7× 273 0.3× 512 0.8× 330 0.6× 383 0.8× 20 2.2k
Pierre L. Goossens France 29 1.1k 0.8× 441 0.5× 335 0.5× 165 0.3× 416 0.9× 61 2.1k
Bärbel Raupach Germany 24 954 0.6× 301 0.4× 935 1.5× 582 1.0× 980 2.2× 28 2.8k
Catherine Grillot‐Courvalin France 28 987 0.6× 482 0.6× 337 0.5× 447 0.8× 566 1.2× 51 2.5k
Kheng B. Lim United States 11 1.1k 0.7× 543 0.7× 144 0.2× 523 0.9× 507 1.1× 14 2.4k
Pierre Dehoux France 24 1.0k 0.7× 197 0.2× 255 0.4× 237 0.4× 159 0.3× 31 2.4k
Sören Abel United States 20 1.2k 0.8× 903 1.1× 200 0.3× 561 1.0× 342 0.8× 29 2.4k
Josette Arondel France 18 694 0.5× 286 0.4× 802 1.3× 1.1k 1.8× 582 1.3× 24 2.2k
Rachel C. Fernandez Canada 27 1.1k 0.7× 746 0.9× 321 0.5× 818 1.4× 444 1.0× 50 2.7k

Countries citing papers authored by V M Gordon

Since Specialization
Citations

This map shows the geographic impact of V M Gordon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by V M Gordon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites V M Gordon more than expected).

Fields of papers citing papers by V M Gordon

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by V M Gordon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by V M Gordon. The network helps show where V M Gordon may publish in the future.

Co-authorship network of co-authors of V M Gordon

This figure shows the co-authorship network connecting the top 25 collaborators of V M Gordon. A scholar is included among the top collaborators of V M Gordon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with V M Gordon. V M Gordon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Gordon, V M, Kim L. Nelson, J. Thomas Buckley, et al.. (1999). Clostridium septicum Alpha Toxin Uses Glycosylphosphatidylinositol-anchored Protein Receptors. Journal of Biological Chemistry. 274(38). 27274–27280. 112 indexed citations
2.
Duesbery, Nicholas S., Craig P. Webb, Stephen H. Leppla, et al.. (1998). Proteolytic Inactivation of MAP-Kinase-Kinase by Anthrax Lethal Factor. Science. 280(5364). 734–737. 824 indexed citations breakdown →
3.
Gordon, V M, Alnawaz Rehemtulla, & S H Leppla. (1997). A role for PACE4 in the proteolytic activation of anthrax toxin protective antigen. Infection and Immunity. 65(8). 3370–3375. 38 indexed citations
4.
Gordon, V M, Roland Benz, K. Fujii, Stephen H. Leppla, & Rodney K. Tweten. (1997). Clostridium septicum alpha-toxin is proteolytically activated by furin. Infection and Immunity. 65(10). 4130–4134. 51 indexed citations
5.
Bosworth, Brad T., James E. Samuel, Harley W. Moon, et al.. (1996). Vaccination with genetically modified Shiga-like toxin IIe prevents edema disease in swine. Infection and Immunity. 64(1). 55–60. 51 indexed citations
6.
Gordon, V M, et al.. (1996). Family Dynamics and Children in Medical Research. The Journal of Clinical Ethics. 7(4). 349–354. 6 indexed citations
7.
Gu, Mili, V M Gordon, D J FitzGerald, & Stephen H. Leppla. (1996). Furin regulates both the activation of Pseudomonas exotoxin A and the Quantity of the toxin receptor expressed on target cells. Infection and Immunity. 64(2). 524–527. 31 indexed citations
8.
Friedman, Theodore C., V M Gordon, Stephen H. Leppla, et al.. (1995). In Vitro Processing of Anthrax Toxin Protective Antigen by Recombinant PC1(SPC3) and Bovine Intermediate Lobe Secretory Vesicle Membranes. Archives of Biochemistry and Biophysics. 316(1). 5–13. 10 indexed citations
9.
Gordon, V M, Kurt R. Klimpel, Naveen Arora, Melodie A. Henderson, & Stephen H. Leppla. (1995). Proteolytic activation of bacterial toxins by eukaryotic cells is performed by furin and by additional cellular proteases. Infection and Immunity. 63(1). 82–87. 208 indexed citations
10.
Samuel, James E. & V M Gordon. (1994). Evidence that proteolytic separation of Shiga-like toxin type IIv A subunit into A1 and A2 subunits is not required for toxin activity.. Journal of Biological Chemistry. 269(7). 4853–4859. 14 indexed citations
11.
Gordon, V M & Stephen H. Leppla. (1994). Proteolytic activation of bacterial toxins: role of bacterial and host cell proteases. Infection and Immunity. 62(2). 333–340. 90 indexed citations
12.
Tesh, Vernon L., et al.. (1993). Comparison of the relative toxicities of Shiga-like toxins type I and type II for mice. Infection and Immunity. 61(8). 3392–3402. 317 indexed citations
13.
Gordon, V M, S. C. Whipp, Harley W. Moon, Alison D. O’Brien, & James E. Samuel. (1992). An enzymatic mutant of Shiga-like toxin II variant is a vaccine candidate for edema disease of swine. Infection and Immunity. 60(2). 485–490. 52 indexed citations
14.
Ehrmann, Ingrid, Mary C. Gray, V M Gordon, L S Gray, & Erik L. Hewlett. (1991). Hemolytic activity of adenylate cyclase toxin fromBordetella pertussis. FEBS Letters. 278(1). 79–83. 86 indexed citations
15.
Hewlett, Erik L., et al.. (1989). Adenylate cyclase toxin from Bordetella pertussis. Journal of Biological Chemistry. 264(32). 19379–19384. 103 indexed citations
16.
Gordon, V M, et al.. (1989). Adenylate Cyclase Toxins from Bacillus anthracis and Bordetella pertussis. Journal of Biological Chemistry. 264(25). 14792–14796. 96 indexed citations
17.
Gordon, V M, et al.. (1985). Inhibition of insulin receptor phosphorylation by indomethacin. Molecular and Cellular Biochemistry. 69(1). 83–91. 5 indexed citations
18.
Gordon, V M, et al.. (1985). Reactivity of the bronchial artery to 5-hydroxytryptamine.. PubMed. 50(3). 325–36. 1 indexed citations
19.
Gordon, V M, T L Innerarity, & Robert W. Mahley. (1983). Formation of cholesterol- and apoprotein E-enriched high density lipoproteins in vitro.. Journal of Biological Chemistry. 258(10). 6202–6212. 126 indexed citations
20.
Bello, Thomas R. & V M Gordon. (1970). Rapid Concentration of Strongyle Eggs from Equine Feces for in Vitro Studies. American Journal of Veterinary Research. 31(12). 2285–2288. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026